Alessia Casolaro

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Barbara Valsasina, Italo Beria, Cristina Alli et al. · Molecular Cancer Therapeutics · 2012 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17

The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56+ Acute Monoblastic Leukaemia

Alessia Casolaro, Josée Golay, Clara Albanese et al. · PLoS ONE · 2013 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15

Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia models

Rachele Alzani, Olga Pedrini, Clara Albanese et al. · Experimental Hematology · 2010 · 15 citations

Medicine, Cancer Biology, Oncology +9